Suppliers / Combino Pharm Malta

Combino Pharm Malta

Malta 2 duplicate records merged Updated 9 July 2026

Combino Pharm Malta is a finished-dose manufacturer based in Malta. It appears in 22 regulatory filings across 7 regulators, without an active US DMF or CEP on file. Its filings concentrate with INFARMED (PT), ARCSA (EC) and MPA (SE). Its GMP standing is certified by EMA and EAEU_EEC. Its most recent recorded inspection, by US FDA, closed on 10 March 2022 as VAI.

0
active US DMFs
0
valid CEPs
3
registered plants 1 with an FDA FEI number
22
filings across 7 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
2 of 2 confirmed
EU GMP
1 of 1 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026. EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.

Inspection history

  • 10 March 2022 VAI US FDA
  • 17 July 2019 VAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
BIRZEBBUGIA, Malta Not on file
Malta, Malta 3009883315
Birzebbuga, Malta Not on file

Filings and GMP by regulator

Regulator Filings GMP certificates
INFARMED (PT) 11 None
ARCSA (EC) 3 None
MPA (SE) 2 None
UZPHARM (UZ) 2 None
MINSA (CR) 2 None
DPM (TN) 1 None
EMA None 1
EAEU_EEC None 1

Comparing suppliers?

Choose your molecules and target markets. Combino Pharm Malta comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was VAI, on 10 March 2022.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates